Julie Smith - 17 Feb 2026 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
Director
Signature
/s/ Nina Ayer, Attorney in Fact
Issuer symbol
EXEL
Transactions as of
17 Feb 2026
Net transactions value
-$2,626,392
Form type
4
Filing time
19 Feb 2026, 19:18:36 UTC
Previous filing
04 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Smith Julie Director C/O EXELIXIS, INC., 1851 HARBOR BAY PARKWAY, ALAMEDA /s/ Nina Ayer, Attorney in Fact 19 Feb 2026 0001557928

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Options Exercise $771,656 +42,422 +206% $18.19 63,012 17 Feb 2026 Direct F1
transaction EXEL Common Stock Sale $1,838,145 -42,422 -67% $43.33 20,590 17 Feb 2026 Direct F1, F2
transaction EXEL Common Stock Options Exercise $854,847 +44,087 +214% $19.39 64,677 18 Feb 2026 Direct F1
transaction EXEL Common Stock Sale $1,961,872 -44,087 -68% $44.50 20,590 18 Feb 2026 Direct F1
transaction EXEL Common Stock Options Exercise $434,451 +20,030 +97% $21.69 40,620 18 Feb 2026 Direct F1
transaction EXEL Common Stock Sale $887,329 -20,030 -49% $44.30 20,590 18 Feb 2026 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXEL Option (right to buy) Options Exercise $0 -42,422 -100% $0.000000 0 17 Feb 2026 Common Stock 42,422 $18.19 Direct F3
transaction EXEL Option (right to buy) Options Exercise $0 -44,087 -100% $0.000000 0 18 Feb 2026 Common Stock 44,087 $19.39 Direct F4
transaction EXEL Option (right to buy) Options Exercise $0 -20,030 -100% $0.000000 0 18 Feb 2026 Common Stock 20,030 $21.69 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 9,812 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
F2 Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $44.30 to $44.44. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3 The option, representing the right to purchase a total of 42,422 shares of Common Stock, became fully exercisable on May 26, 2022.
F4 The option, representing the right to purchase a total of 44,087 shares of Common Stock, became fully exercisable on June 1, 2023.
F5 The option, representing the right to purchase a total of 20,030 shares of Common Stock, became fully exercisable on May 31, 2024.